We are live on
!
Find out more
WINT
Windtree Therapeutics
WINT
WINT
Delisted
WINT was delisted on the 20th of August, 2025.
8 hedge funds and large institutions have $1.76M invested in Windtree Therapeutics in 2022 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
0% less ownership
Funds ownership: 0% → 0% (-0%)
11% less funds holding
Funds holding: 9 → 8 (-1)
35% less capital invested
Capital invested by funds: $2.72M → $1.76M (-$967K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 3
Holders
8
Holders Change
-1
Holders Change %
-11.11%
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$157K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$66K |
| 3 |
Northern Trust
Chicago,
Illinois
|
-$52.5K |
| 4 |
Two Sigma Advisers
New York
|
-$52.5K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$21K |